Construction of an adverse outcome pathway framework for arsenic-induced lung cancer using a network-based approach.
Cheng C, Fan B, Yang Y, Wang P, Wu M, Xia H, Syed BM, Wu H, Liu Q.
Ecotoxicol Environ Saf. 2024 Sep 15;283:116809. doi: 10.1016/j.ecoenv.2024.116809. Epub 2024 Jul 30.
Heavy metals: toxicity and human health effects.
Jomova K, Alomar SY, Nepovimova E, Kuca K, Valko M.
Arch Toxicol. 2025 Jan;99(1):153-209. doi: 10.1007/s00204-024-03903-2. Epub 2024 Nov 20.
Arsenic-induced prostate cancer: an enigma.
Mukherjee AG, Gopalakrishnan AV.
Med Oncol. 2024 Jan 6;41(2):50. doi: 10.1007/s12032-023-02266-5.
miRNAs and arsenic-induced carcinogenesis.
Nail AN, Ferragut Cardoso AP, Montero LK, States JC.
Adv Pharmacol. 2023;96:203-240. doi: 10.1016/bs.apha.2022.10.002. Epub 2023 Feb 6.
Arsenic-induced changes in miRNA expression in cancer and other diseases.
Ferragut Cardoso AP, Udoh KT, States JC.
Toxicol Appl Pharmacol. 2020 Dec 15;409:115306. doi: 10.1016/j.taap.2020.115306. Epub 2020 Oct 28.
Characterization of Arsenic-Induced Cancer Stem-Like Cells.
Chang Q, Bi Z, Fu Y, Rice MKA, Zhang Q, Wadgaonkar P, Almutairy B, Zhang W, Lu Y, Xu L, Thukar C, Chen F.
Methods Mol Biol. 2020;2117:293-303. doi: 10.1007/978-1-0716-0301-7_19.
Arsenic and cancer: Evidence and mechanisms.
Speer RM, Zhou X, Volk LB, Liu KJ, Hudson LG.
Adv Pharmacol. 2023;96:151-202. doi: 10.1016/bs.apha.2022.08.001. Epub 2022 Sep 27.
Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells.
Li L, Bi Z, Wadgaonkar P, Lu Y, Zhang Q, Fu Y, Thakur C, Wang L, Chen F.
Semin Cancer Biol. 2019 Aug;57:10-18. doi: 10.1016/j.semcancer.2019.04.003. Epub 2019 Apr 19.
Molecular features in arsenic-induced lung tumors.
Hubaux R, Becker-Santos DD, Enfield KS, Rowbotham D, Lam S, Lam WL, Martinez VD.
Mol Cancer. 2013 Mar 19;12:20. doi: 10.1186/1476-4598-12-20.
MiR-218-5p/EGFR Signaling in Arsenic-Induced Carcinogenesis.
Islam R, Zhao L, Zhang X, Liu LZ.
Cancers (Basel). 2023 Feb 14;15(4):1204. doi: 10.3390/cancers15041204.
